Aim. Chronic fatigue (CF) severely affects patients with mul-tiple sclerosis (MS), but its
pathogenesis remains elusive and the effectiveness of available treatments is modest. We …

Background and purpose A new treatable venous disorder, chronic cerebrospinal venous
insufficiency (CCSVI), has been proposed in patients with multiple sclerosis (MS). Its …

Background Chronic Cerebrospinal Venous Insufficiency (CCSVI) has been associated with
multiple sclerosis (MS) with a risk ranging from as high as two-hundred-fold to a protective …

Background This study aimed to investigate the prevalence and clinical relevance of chronic
cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis (MS) patients and healthy …

Background There is a significant increase in the parenchymal microvessel blood volume in
the earliest forms of multiple sclerosis (MS) which may be due to venular dilatation …

Chronic cerebrospinal venous insufficiency (CCSVI) is a term used to describe impaired
venous drainage from the central nervous system (CNS) caused by abnormalities in …

Background Chronic cerebrospinal venous insufficiency (CCSVI) has recently been reported
to be associated with multiple sclerosis (MS). However, its actual prevalence, possible …

Purpose To investigate the relationship between chronic cerebrospinal venous insufficiency
(CCSVI) and cerebral hemodynamic parameters and to disclose any possible involvement …

Objective Multiple sclerosis (MS) is a chronic neurodegenerative disease of the CNS.
Recently a controversial vascular hypothesis for MS, termed chronic cerebrospinal venous …

Objective: Chronic cerebrospinal venous insufficiency (CCSVI) had been suggested to play
a major pathogenetic role in multiple sclerosis (MS), but recent data on early stages of MS …